Molecular Therapeutics: 21st-Century Medicine / Edition 1

Hardcover (Print)
Buy New
Buy New from
Used and New from Other Sellers
Used and New from Other Sellers
from $155.95
Usually ships in 1-2 business days
(Save 20%)
Other sellers (Hardcover)
  • All (7) from $155.95   
  • New (5) from $155.95   
  • Used (2) from $180.44   


Molecular therapeutics incorporates genetics, recombinant DNA technology, biochemistry, protein production and purification, microbiology, molecular biology, immunology, pathobiology, and biotechnology. It addresses the treatment of human beings with "new drugs" and poses a range of ethical issues, particularly with respect to clinical trials, animal models, financial considerations and availability of treatment.

Recent advances in molecular therapeutics means that many of these cutting edge methods will soon be ready to be considered for clinical trial. It is essential that scientists, doctors, nurses and allied health professionals involved in these novel therapies understand how these techniques have evolved, what their benefits and drawbacks might be, the ethical issues associated with them and what their potential is for the future.

Targeted at postgraduate and undergraduate biomedical, allied health, medical and life science students, 'Molecular Therapeutics' provides an invaluable introduction to this rapidly evolving field. the exploration of a broad range of novel approaches and disciplines including; making recombinant proteins, xenotransplantation, gene therapy and therapeutic cloning, combines analysis and technologies with the ethics of molecular therapy, a wealth of clinically relevant examples to engage and maintain student interest, an associated website that includes a web forum, self assessment exercises and reference updates.

About the Author:
Pamela Greenwell is Principal Lecturer at The University of Westminster

About the Author:
Michelle McCulley is a Senior Teaching fellow at the Peninsula Medical School

Read More Show Less

Product Details

  • ISBN-13: 9780470019160
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 1/18/2008
  • Edition number: 1
  • Pages: 264
  • Product dimensions: 6.93 (w) x 9.90 (h) x 0.83 (d)

Table of Contents


1 Introduction.
1.1 Microbial diseases.
1.2 Cancer and heart disease.
1.3 Genetic diseases.
1.4 Role of molecular biology in therapeutics.

2 Prenatal diagnosis and pre-implementation.

2.1 Should we treat inherited diseases?
2.2 Genetic screening.
2.2.1 Pre-implementation genetic diagnosis.
2.3 Counselling.

3 Simple protein replacement therapy.
3.1 Preventing transfusion-transmissible infectious diseases in the UK.
3.2 Ensuring the safety of organ transplants.
3.3 Preventing transfusion-transmissible infectious diseases worldwide.
3.4 HIV.

4 Recombinant protein production.

4.1 Choice of organism.
4.2 Alternatives to E. coli for the production of recombinant proteins.
4.3 Problems with recombinant protein production.
4.4 All recombinants must be tested before they are given to humans.
4.5 Why make recombinant proteins?
4.6 Recombinant products.
4.7 Generics.

5 Recombinant vaccines.

5.1 Vaccine history.
5.2 Vaccines.
5.3 Vaccine methods.
5.4 Types of vaccine.
5.5 The limitations of vaccine programmes.
5.6 The role of the WHO.
5.7 Problems specific to developing countries.
5.8 Economics and logistics of vaccinology.
5.9 Recombinant vaccines.
5.10 Rational design: bioinformatics and proteomics.
5.11 Other interesting areas for vaccine development.
5.12 Conclusion.

6 Therapeutic antibodies and immunotherapy.
6.1 Monoclonal antibodies.
6.2 Monoclonal production.
6.3 Therapeutic monoclonal antibodies.
6.4 Transgenic monoclonals.
6.5 The uses of monoclonal antibodies in therapy.
6.6 Specific examples of therapeutic strategies.
6.7 Other recombinant proteins used in immunotherapy.

7 Transgenic animals.
7.1 Why do we want to engineer the genomes of animals?
7.2 Experimental procedure.
7.3 DNA constructs, insertional mutagenesis and homologous recombination.
7.4 Uses of inducible and tissue-specific promoters.
7.5 Introduction of the DNA into the cells.
7.6 Uses of transgenics.

8 Transplantation: a form of gene therapy.
8.1 Introduction.
8.2 Bone marrow.
8.3 Solid organ transplantation.
8.4 Other cells and tissues.
8.5 Summary of the problems associated with transplantation.
8.6 Transplantation statistics.
8.7 Legislation.
8.8 Religious beliefs and transplantation.

9 Xenotransplantation.

9.1 Introduction.
9.2 Rationale for the use of non-human donors.
9.3 Organs from non-human primates.
9.4 Pigs.
9.5 Problems with pigs.
9.6 Government legislation.
9.7 When will xenotransplantation start?
9.8 Patient attitudes.
9.9 Ethics.
9.10 Alternatives to xenotransplants.

10 Reproductive cloning

10.1 History.
10.2 Problems.
10.3 Why was there so much interest in Dolly?
10.4 Was Dolly a lone example?
10.5 Why is cloning useful?
10.6 Is human cloning a reality?
10.7 Why can we not produce human clones that are identical?
10.8 So why clone humans?
10.9 What are the ethical and moral problems?

11 Stem cell therapy.

11.1 The potency of cells.
11.2 Cloning.
11.3 Potency of stem cells.
11.4 Potential sources of stem cells.
11.5 Stem cells and therapeutic cloning.
11.6 Legislation and therapeutic cloning.
11.7 Other sources of stem cells.
11.8 What can be done?
11.9 Experiments on embryonic cells.
11.10 Experiments on fetal tissue and cord blood.
11.11 Stem cells from adult tissues.
11.12 Safety and technical problems.
11.13 Perceived scope of therapy.
11.14 Clinical trials of stem cell therapy.
11.15 What are the future prospects for stem cell research?

12 Gene augmentation therapy.

12.1 Introduction.
12.2 Strategy.

13 Gene therapy trials for inherited diseases.

13.1 Introduction.
13.2 Examples of disease treated with retroviral gene therapy.
13.3 Cystic fibrosis.
13.4 Animal trials with Factor IX.
13.5 Adenoviruses have also been used to introduce genes into brain.
13.6 Duchenne's muscular dystrophy.
13.7 Problems with adenoviruses.
13.8 The uses of adeno-associated viruses.
13.9 Liposome vector trials.
13.10 Trials with polymer mareix delivery.

14 Gene silencing technologies.

14.1 Antisense therapy.
14.2 Triple helix (triplex) technology.
14.3 Ribozymes.
14.4 Small interfering RNAs (siRNAs).

15 Gene therapy for cancer.

15.1 What causes cancer?
15.2 Cancer: a multifactorial disease.
15.3 Cancer statistics.
15.4 Best treatment currently available.
15.5 Do chemo- and radiotherapy cause problems?
15.6 New cancer therapies.
15.7 Cancer models in animals.
15.8 What kinds of gene therapy can we use to treat cancer?
15.9 Perceived problems in cancer gene augmentation therapy.
15.10 Gene silencing technologies and cancer.
15.11 Conclusion.

16 Single-nucleotide polymorphisms (SNPs) and therapy.

17 Legislation, clinical trials and ethical issues.
17 Legislation, clinical trials and ethical issues.
17.1 Legislative bodies.
17.2 Clinical trials.
17.3 The problems of placebo controlled trials.
17.4 The need for informed consent.
17.5 Trials in developing countries.
17.6 Recent trial issues.
17.7 Conclusion.

Sourcing references.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)